$1.51
0.0%
Downside
Day's Volatility :9.58%
Upside
9.58%
11.26%
Downside
52 Weeks Volatility :77.28%
Upside
74.4%
Period | China Jo-jo Drugstores Inc | Index (Russel 2000) |
---|---|---|
3 Months | -47.86% | 0.0% |
6 Months | -47.56% | 0.0% |
1 Year | -73.04% | 0.0% |
3 Years | -99.12% | -22.3% |
Market Capitalization | 11.0M |
Book Value | $8.97 |
Earnings Per Share (EPS) | -2.93 |
PEG Ratio | 0.0 |
Wall Street Target Price | 7.0 |
Profit Margin | -2.74% |
Operating Margin TTM | -4.99% |
Return On Assets TTM | -2.38% |
Return On Equity TTM | -27.35% |
Revenue TTM | 154.5M |
Revenue Per Share TTM | 107.0 |
Quarterly Revenue Growth YOY | -0.2% |
Gross Profit TTM | 34.3M |
EBITDA | -2.8M |
Diluted Eps TTM | -2.93 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 363.58%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 107.6M | ↑ 11.9% |
Net Income | -1.3M | ↓ 92.28% |
Net Profit Margin | -1.23% | ↑ 16.52% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 117.3M | ↑ 9.09% |
Net Income | -6.5M | ↑ 390.05% |
Net Profit Margin | -5.5% | ↓ 4.27% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 133.1M | ↑ 13.47% |
Net Income | -8.4M | ↑ 29.7% |
Net Profit Margin | -6.29% | ↓ 0.79% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 164.4M | ↑ 23.48% |
Net Income | -3.2M | ↓ 61.81% |
Net Profit Margin | -1.95% | ↑ 4.34% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 148.8M | ↓ 9.48% |
Net Income | -21.1M | ↑ 560.92% |
Net Profit Margin | -14.21% | ↓ 12.26% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 154.5M | ↑ 3.85% |
Net Income | -4.2M | ↓ 79.97% |
Net Profit Margin | -2.74% | ↑ 11.47% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 62.3M | - |
Net Income | 4.8M | - |
Net Profit Margin | 7.68% | - |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 72.7M | - |
Net Income | -594.8K | - |
Net Profit Margin | -0.82% | - |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 39.3M | ↓ 45.98% |
Net Income | -462.1K | ↓ 22.3% |
Net Profit Margin | -1.18% | ↓ 0.36% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 39.3M | ↑ 0.0% |
Net Income | -462.1K | ↑ 0.0% |
Net Profit Margin | -1.18% | ↑ 0.0% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 38.0M | ↓ 3.32% |
Net Income | -1.7M | ↑ 258.13% |
Net Profit Margin | -4.36% | ↓ 3.18% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 72.7M | ↓ 1.47% |
Total Liabilities | 55.8M | ↑ 1.47% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 99.5M | ↑ 36.83% |
Total Liabilities | 80.7M | ↑ 44.8% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 106.3M | ↑ 6.83% |
Total Liabilities | 81.9M | ↑ 1.45% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 106.4M | ↑ 0.07% |
Total Liabilities | 83.6M | ↑ 2.12% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 91.0M | ↓ 14.49% |
Total Liabilities | 74.3M | ↓ 11.17% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 95.1M | ↑ 4.49% |
Total Liabilities | 80.8M | ↑ 8.69% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 101.8M | ↑ 0.0% |
Total Liabilities | 79.8M | ↑ 0.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 94.8M | ↓ 6.88% |
Total Liabilities | 77.2M | ↓ 3.26% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 94.8M | ↑ 0.0% |
Total Liabilities | 77.2M | ↑ 0.0% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 94.8M | ↑ 0.0% |
Total Liabilities | 77.2M | ↑ 0.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 95.1M | ↑ 0.31% |
Total Liabilities | 80.8M | ↑ 4.58% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 95.1M | ↑ 0.0% |
Total Liabilities | 80.8M | ↑ 0.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -5.6M | ↑ 170.68% |
Investing Cash Flow | -7.3M | ↑ 146.05% |
Financing Cash Flow | 8.1M | ↓ 1147.89% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -6.9M | ↑ 23.29% |
Investing Cash Flow | -4.8M | ↓ 33.98% |
Financing Cash Flow | 19.0M | ↑ 135.36% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -62.3K | ↓ 99.1% |
Investing Cash Flow | -2.0M | ↓ 58.68% |
Financing Cash Flow | 3.1M | ↓ 83.8% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -5.4M | ↑ 8546.33% |
Investing Cash Flow | -306.1K | ↓ 84.68% |
Financing Cash Flow | 4.8M | ↑ 57.05% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -3.3M | ↓ 39.04% |
Investing Cash Flow | -316.1K | ↑ 3.25% |
Financing Cash Flow | 2.4M | ↓ 51.08% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -10.8M | ↑ 267.21% |
Investing Cash Flow | -116.3K | ↑ 93.79% |
Financing Cash Flow | 11.2M | ↑ 1493.79% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.2M | ↓ 79.91% |
Investing Cash Flow | -116.3K | ↑ 0.0% |
Financing Cash Flow | 2.7M | ↓ 76.18% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.2M | ↑ 0.0% |
Investing Cash Flow | -116.3K | ↑ 0.0% |
Financing Cash Flow | 2.7M | ↑ 0.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 361.4K | ↓ 116.65% |
Investing Cash Flow | -116.3K | ↑ 0.0% |
Financing Cash Flow | 164.0K | ↓ 93.87% |
Sell
Neutral
Buy
China Jo-jo Drugstores Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() China Jo-jo Drugstores Inc | -33.18% | -47.56% | -73.04% | -99.12% | -99.46% |
![]() Petmed Express Inc | 4.11% | -34.33% | -69.93% | -88.24% | -79.93% |
![]() Trxade Health Inc | -5.58% | -66.16% | -42.49% | -91.61% | -93.41% |
![]() Walgreens Boots Alliance, Inc. | -18.65% | -58.12% | -60.21% | -82.8% | -84.22% |
![]() High Tide Inc | 14.62% | 20.25% | 23.27% | -73.83% | -78.22% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() China Jo-jo Drugstores Inc | NA | NA | 0.0 | 0.0 | -0.27 | -0.02 | NA | 8.97 |
![]() Petmed Express Inc | 1191.0 | NA | 2.58 | -0.19 | -0.03 | 0.0 | NA | 4.56 |
![]() Trxade Health Inc | NA | NA | NA | 0.0 | -2.69 | -0.72 | 0.0 | 8.38 |
![]() Walgreens Boots Alliance, Inc. | 27.42 | NA | 3.55 | 2.57 | -0.56 | 0.01 | 0.11 | 15.8 |
![]() High Tide Inc | NA | NA | NA | -0.03 | -0.23 | 0.02 | NA | 1.76 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() China Jo-jo Drugstores Inc | NA | $11.0M | -99.46% | NA | -2.74% |
![]() Petmed Express Inc | Sell | $69.6M | -79.93% | 1191.0 | -0.95% |
![]() Trxade Health Inc | Buy | $12.4M | -93.41% | NA | 56.68% |
![]() Walgreens Boots Alliance, Inc. | Hold | $7.6B | -84.22% | 27.42 | -3.99% |
![]() High Tide Inc | Buy | $158.9M | -78.22% | NA | -6.82% |
Insights on China Jo-jo Drugstores Inc
In the last 1 year, High Tide Inc has given 23.3% return, outperforming this stock by 96.3%
In the last 3 years, China Jo-jo Drugstores Inc has experienced a drawdown of -99.1%, however High Tide Inc resisted the overall trend and outperformed by 25.3%
Hillhouse Capital Advisors, Ltd.
UBS Group AG
Organization | China Jo-jo Drugstores Inc |
Employees | 939 |
CEO | Mr. Lei Liu M.D. |
Industry | Retail Trade |
A Spac I Acquisition Corp
$1.51
-8.41%
Keyarch Acquisition Corp
$1.51
-8.41%
Connexa Sports Technologies Inc
$1.51
-8.41%
Us Value Etf
$1.51
-8.41%
First Wave Biopharma Inc
$1.51
-8.41%
Global X Msci Next Emerging
$1.51
-8.41%
Fat Projects Acquisition Corp
$1.51
-8.41%
Capital Link Global Fintech
$1.51
-8.41%
Applied Uv Inc
$1.51
-8.41%